From: Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events
Response
Number of patients (%)
Radiographic response
-complete response
0
-partial response
11 (47.8%)
-stable disease
5 (21.7%)
-disease progression
7 (30.4%)
Clinical benefit
-yes
14 (60.9%)
-no
9 (39.1%)